BCL2 and hepatocellular carcinoma: An increased expression of anti-apoptotic members of the Bcl-2 protein family (Bcl-XL and Mcl-1), which are localized to the mitochondria in HCC cells, can induce resistance to regorafenib and sorafenib (27, 28).